Assay ID | Title | Year | Journal | Article |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | | | |
AID1745845 | Primary qHTS for Inhibitors of ATXN expression | | | |
AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
AID404069 | In vivo antitumor activity against mouse L1210 cells | | | |
AID513959 | Cytotoxicity against human HT-29 cells | 2010 | Bioorganic & medicinal chemistry, Jul-15, Volume: 18, Issue:14
| Identification of chalcones as in vivo liver monofunctional phase II enzymes inducers. |
AID461713 | Selectivity for human MAOB over human MAOA | 2010 | Bioorganic & medicinal chemistry, Feb, Volume: 18, Issue:3
| A new series of flavones, thioflavones, and flavanones as selective monoamine oxidase-B inhibitors. |
AID295380 | Cytotoxicity against human TK10 cells in aerobic condition assessed as survival at 100 uM by sulforhodamine assay | 2007 | Bioorganic & medicinal chemistry, May-15, Volume: 15, Issue:10
| Synthetic chalcones, flavanones, and flavones as antitumoral agents: biological evaluation and structure-activity relationships. |
AID295381 | Cytotoxicity against human MCF7 cells ATCC HTB38 in aerobic condition assessed as survival at 100 uM by sulforhodamine assay | 2007 | Bioorganic & medicinal chemistry, May-15, Volume: 15, Issue:10
| Synthetic chalcones, flavanones, and flavones as antitumoral agents: biological evaluation and structure-activity relationships. |
AID404067 | In vivo antitumor activity against mouse S180 cells | | | |
AID404070 | In vivo antitumor activity against mouse CA-755 cells | | | |
AID513957 | Cytotoxicity against human MCF7 cells | 2010 | Bioorganic & medicinal chemistry, Jul-15, Volume: 18, Issue:14
| Identification of chalcones as in vivo liver monofunctional phase II enzymes inducers. |
AID461712 | Inhibition of human recombinant MAOB expressed in BTI-TN-5B1-4 cells by para-tyramine oxidation assay | 2010 | Bioorganic & medicinal chemistry, Feb, Volume: 18, Issue:3
| A new series of flavones, thioflavones, and flavanones as selective monoamine oxidase-B inhibitors. |
AID295382 | Cytotoxicity against human HT29 cells ATCC HTB38 in aerobic condition assessed as survival at 100 uM by sulforhodamine assay | 2007 | Bioorganic & medicinal chemistry, May-15, Volume: 15, Issue:10
| Synthetic chalcones, flavanones, and flavones as antitumoral agents: biological evaluation and structure-activity relationships. |
AID353303 | Increase in EGR1 mRNA expression in human HEK293 cells at 20 ug/mL after 6 to 12 hrs by dual-glo luciferase assay relative to control | 2009 | Bioorganic & medicinal chemistry letters, Apr-15, Volume: 19, Issue:8
| Relationships between the structures of flavanone derivatives and their effects in enhancing early growth response-1 gene expression. |
AID1090146 | Antifungal activity against against Magnaporthe grisea | 2005 | Journal of agricultural and food chemistry, Mar-09, Volume: 53, Issue:5
| Binding model construction of antifungal 2-aryl-4-chromanones using CoMFA, CoMSIA, and QSAR analyses. |
AID461710 | Inhibition of human recombinant MAOA expressed in BTI-TN-5B1-4 cells at 100 uM by para-tyramine oxidation assay | 2010 | Bioorganic & medicinal chemistry, Feb, Volume: 18, Issue:3
| A new series of flavones, thioflavones, and flavanones as selective monoamine oxidase-B inhibitors. |
AID513976 | Toxicity in Sprague-Dawley rat assessed as glutamic-pyruvate level at 250 mg/kg, po (RVb = 22.8 +/-13.2 U/L) | 2010 | Bioorganic & medicinal chemistry, Jul-15, Volume: 18, Issue:14
| Identification of chalcones as in vivo liver monofunctional phase II enzymes inducers. |
AID513978 | Toxicity in Sprague-Dawley rat assessed as change in body weight at 250 mg/kg, po | 2010 | Bioorganic & medicinal chemistry, Jul-15, Volume: 18, Issue:14
| Identification of chalcones as in vivo liver monofunctional phase II enzymes inducers. |
AID513975 | Toxicity in Sprague-Dawley rat assessed as haemoglobin level at 250 mg/kg, po (RVb = 15.1 +/- 4.1 g/L) | 2010 | Bioorganic & medicinal chemistry, Jul-15, Volume: 18, Issue:14
| Identification of chalcones as in vivo liver monofunctional phase II enzymes inducers. |
AID513958 | Cytotoxicity against human TK10 cells | 2010 | Bioorganic & medicinal chemistry, Jul-15, Volume: 18, Issue:14
| Identification of chalcones as in vivo liver monofunctional phase II enzymes inducers. |
AID513974 | Toxicity in Sprague-Dawley rat assessed as leucocyte level at 250 mg/kg, po (RVb = 200 +/- 1500 /uL) | 2010 | Bioorganic & medicinal chemistry, Jul-15, Volume: 18, Issue:14
| Identification of chalcones as in vivo liver monofunctional phase II enzymes inducers. |
AID513977 | Toxicity in Sprague-Dawley rat assessed as glutamic-oxalate transaminase level at 250 mg/kg, po (RVb = 71.4 +/- 7.8 U/L) | 2010 | Bioorganic & medicinal chemistry, Jul-15, Volume: 18, Issue:14
| Identification of chalcones as in vivo liver monofunctional phase II enzymes inducers. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |